Budesonide Formoterol Rotacaps Inhaler
utilized to alleviate airway inflammation, to support respiratory function.
Strengths: 100/6 · 200/6 · 400/6mcg
Where to Check Availability
Medicine details
- Alternative names
Symbicort; Duoresp Spiromax; Budesonide Formoterol Inhaler
- Therapeutic class
Corticosteroid; Beta2-Agonist
- Pharmacological class
Inhaled Corticosteroid; Long-acting Beta2-Agonist
- Contraindications
hypersensitivity to active ingredients
- Precautions and warnings
rinse mouth after use to prevent oral candidiasis; monitor respiratory function
- Minor side effects
tremor; palpitations; oral candidiasis
- Moderate side effects
hoarseness; muscle cramps
- Dosage forms
Inhalation powder, hard capsule
- Administration route
Inhalation use
- Patient summary
utilized to alleviate airway inflammation, to support respiratory function.
- Prescription status
POM
- Manufacturer
AstraZeneca
- Onset Time
1–3 minutes
- Duration
12 hours
- Storage instructions
Store below 30°C. Protect from moisture.
- Drug interactions
beta-blockers
- Age restrictions
Consult age-specific guidelines for inhaler use.
Serious side effects
bronchospasm — requires immediate medical attention; anaphylaxis — requires immediate medical attention
Mechanism of action
Budesonide provides anti-inflammatory effects by suppressing airway inflammation, while formoterol acts as a long-acting beta2-agonist to induce bronchial smooth muscle relaxation.
Pregnancy and breastfeeding
Pregnancy: Use as directed by physician. Breastfeeding: Generally considered safe in therapeutic doses.
Budesonide Formoterol Rotacaps Inhaler
utilized to alleviate airway inflammation, to support respiratory function.
Editorial Notes
- Active ingredient(s): Budesonide, Formoterol
- Listed indication(s): Asthma, Chronic Obstructive Pulmonary Disease
Available option
- 90 capsules - 400/6 mcg1275-400-6-mcg-17377